Dose-Dependent Olanzapine-Induced Myoclonus

Second-generation antipsychotics (SGA), mainly clozapine have been reported to induce myoclonus. Although olanzapine-induced myoclonus is reported, dose-dependent response has not been described. We report dose-related olanzapine-induced myoclonus in an early onset schizophrenia patient. We also sug...

Descripción completa

Detalles Bibliográficos
Autores principales: Tikka, Sai Krishna, Pratap, Alok, Sinha, Vinod Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413423/
https://www.ncbi.nlm.nih.gov/pubmed/25948979
http://dx.doi.org/10.4103/0971-6580.155393
_version_ 1782368780227182592
author Tikka, Sai Krishna
Pratap, Alok
Sinha, Vinod Kumar
author_facet Tikka, Sai Krishna
Pratap, Alok
Sinha, Vinod Kumar
author_sort Tikka, Sai Krishna
collection PubMed
description Second-generation antipsychotics (SGA), mainly clozapine have been reported to induce myoclonus. Although olanzapine-induced myoclonus is reported, dose-dependent response has not been described. We report dose-related olanzapine-induced myoclonus in an early onset schizophrenia patient. We also suggest certain management strategies for such adverse side effects.
format Online
Article
Text
id pubmed-4413423
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-44134232015-05-06 Dose-Dependent Olanzapine-Induced Myoclonus Tikka, Sai Krishna Pratap, Alok Sinha, Vinod Kumar Toxicol Int Case Report Second-generation antipsychotics (SGA), mainly clozapine have been reported to induce myoclonus. Although olanzapine-induced myoclonus is reported, dose-dependent response has not been described. We report dose-related olanzapine-induced myoclonus in an early onset schizophrenia patient. We also suggest certain management strategies for such adverse side effects. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4413423/ /pubmed/25948979 http://dx.doi.org/10.4103/0971-6580.155393 Text en Copyright: © Toxicology International http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Tikka, Sai Krishna
Pratap, Alok
Sinha, Vinod Kumar
Dose-Dependent Olanzapine-Induced Myoclonus
title Dose-Dependent Olanzapine-Induced Myoclonus
title_full Dose-Dependent Olanzapine-Induced Myoclonus
title_fullStr Dose-Dependent Olanzapine-Induced Myoclonus
title_full_unstemmed Dose-Dependent Olanzapine-Induced Myoclonus
title_short Dose-Dependent Olanzapine-Induced Myoclonus
title_sort dose-dependent olanzapine-induced myoclonus
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413423/
https://www.ncbi.nlm.nih.gov/pubmed/25948979
http://dx.doi.org/10.4103/0971-6580.155393
work_keys_str_mv AT tikkasaikrishna dosedependentolanzapineinducedmyoclonus
AT pratapalok dosedependentolanzapineinducedmyoclonus
AT sinhavinodkumar dosedependentolanzapineinducedmyoclonus

Ejemplares similares